Open Access
Issue
BIO Web Conf.
Volume 111, 2024
2024 6th International Conference on Biotechnology and Biomedicine (ICBB 2024)
Article Number 03001
Number of page(s) 5
Section Medical Testing and Health Technology Integration
DOI https://doi.org/10.1051/bioconf/202411103001
Published online 31 May 2024
  • Blennow K., de Leon M.J., Zetterberg H. Alzheimer's disease. Lancet. 2006 Jul 29;368(9533):387–403. doi: 10.1016/S0140-6736(06)69113-7. PMID: 16876668. [CrossRef] [Google Scholar]
  • Knopman D.S., DeKosky S.T., Cummings J.L., et al. Practice parameter: diagnosisbof dementia (anevidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:1143–1153. [CrossRef] [PubMed] [Google Scholar]
  • Lista S., O'Bryant, S.E., Blennow, K., Dubois, B., Hugon, J., Zetterberg, H., Hampel, H. Biomarkers in Sporadic and Familial Alzheimer's Disease. J Alzheimers Dis. 2015; 47(2):291–317. doi: 10.3233/JAD-143006. PMID: 26401553. [CrossRef] [Google Scholar]
  • Piaceri I., Nacmias B., Sorbi S. Genetics of familial and sporadic Alzheimer's disease. Front Biosci (Elite Ed). 2013 Jan 1;5(1):167–77. doi: 10.2741/e605. PMID: 23276979. [CrossRef] [Google Scholar]
  • Li X., Cao Y. Current status of familial Alzheimer's disease research[J]. Journal of International Neurology and Neurosurgery, 2014, 41(02): 156–159. DOI: 10.16636/j.cnki.jinn.2014.02.024. [Google Scholar]
  • Petersen R.C., Smith G., Kokmen E., Ivnik R.J., Tangalos E.G. Memory function in normal aging. Neurology. 1992 Feb;42(2):396–401. doi: 10.1212/wnl.42.2.396. PMID: 1736173. [CrossRef] [PubMed] [Google Scholar]
  • Chávez-Gutiérrez L., Szaruga M. Mechanisms of neurodegeneration - Insights from familial Alzheimer's disease. Semin Cell Dev Biol. 2020 Sep; 105:75–85. doi: 10.1016/j.semcdb.2020.03.005. Epub 2020 May 14. PMID: 32418657. [CrossRef] [Google Scholar]
  • Y. Jia, N. Wang, Y. Zhang, D. Xue, H. Lou, and X. Liu, ‘Alteration in the Function and Expression of SLC and ABC Transporters in the Neurovascular Unit in Alzheimer’s Disease and the Clinical Significance’, Aging Dis, vol. 11, no. 2, pp. 390–404, Mar. 2020, doi: 10.14336/AD.2019.0519. [CrossRef] [PubMed] [Google Scholar]
  • F. L. Yeh, Y. Wang, I. Tom, L. C. Gonzalez, and M. Sheng, ‘TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia’, Neuron, vol. 91, no. 2, pp. 328–340, Jul. 2016, doi: 10.1016/j.neuron.2016.06.015. [CrossRef] [PubMed] [Google Scholar]
  • A. Armstrong, Richard. "Review article What causes alzheimer’s disease?." Folia Neuropathologica, vol. 51, no. 3, 2013, pp. 169–188. doi: 10.5114/fn.2013.37702. [CrossRef] [Google Scholar]
  • Chen Y., Liang Z., Blanchard J., Dai C.L., Sun S., Lee M.H., Grundke-Iqbal I., Iqbal K., Liu F., Gong C.X. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Mol Neurobiol. 2013 Apr; 47(2):711–25. doi: 10.1007/s12035-012-8375-5. Epub 2012 Nov 14. PMID: 23150171; PMCID: PMC3582864. [CrossRef] [PubMed] [Google Scholar]
  • Scheltens P., De Strooper B., Kivipelto M., Holstege H., Chételat G., Teunissen C.E., Cummings J., van der Flier W.M. Alzheimer's disease. Lancet. 2021 Apr 24; 397(10284): 1577–1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2. PMID: 33667416; PMCID: PMC8354300. [CrossRef] [Google Scholar]
  • Mirza A., King A., Troakes C., Exley C. Aluminium in brain tissue in familial Alzheimer's disease. J Trace Elem Med Biol. 2017 Mar; 40:30–36. doi: 10.1016/j.jtemb.2016.12.001. Epub 2016 Dec 9. PMID: 28159219. [CrossRef] [Google Scholar]
  • Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P.J., Scheltens, P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007 Aug;6(8):734–46. doi: 10.1016/S1474-4422(07)70178-3. PMID: 17616482. [CrossRef] [Google Scholar]
  • M. A. DeMichele-Sweet and R. A. Sweet, ‘Genetics of Psychosis in Alzheimer’s Disease: A Review’, Journal of Alzheimer’s Disease, vol. 19, no. 3, pp. 761–780, Jan. 2010, doi: 10.3233/JAD-2010-1274. [CrossRef] [Google Scholar]
  • E. A. Schon and E. Area-Gomez, ‘Is Alzheimer’s Disease a Disorder of Mitochondria-Associated Membranes?’, Journal of Alzheimer’s Disease, vol. 20, no. s2, pp. S281–S292, Jun. 2010, doi: 10.3233/JAD-2010-100495. [CrossRef] [Google Scholar]
  • Li X., Westman E., Ståhlbom A.K., Thordardottir S., Almkvist O., Blennow K., Wahlund L.O., Graff C. White matter changes in familial Alzheimer's disease. J Intern Med. 2015 Aug;278(2):211–8. doi: 10.1111/joim.12352. Epub 2015 Mar 12. PMID: 25639959. [CrossRef] [PubMed] [Google Scholar]
  • Ochalek A., Mihalik B., Avci H.X., Chandrasekaran A., Téglási A., Bock I., Giudice M.L., Táncos Z., Molnár K., László L., Nielsen J.E., Holst B., Freude K., Hyttel P., Kobolák J., Dinnyés A. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation. Alzheimers Res Ther. 2017 Dec 1;9(1):90. doi: 10.1186/s13195-017-0317-z. PMID: 29191219; PMCID: PMC5709977. [CrossRef] [Google Scholar]
  • Swearer J.M., O'Donnell, B.F., Ingram, S.M., Drachman D.A. Rate of progression in familial Alzheimer's disease. J Geriatr Psychiatry Neurol. 1996 Jan;9(1):22–5. doi: 10.1177/089198879600900104. PMID: 8679059. [CrossRef] [PubMed] [Google Scholar]
  • Dinkel F., Trujillo-Rodriguez D., Villegas A., Streffer J., Mercken M., Lopera F., Glatzel M., Sepulveda-Falla D. Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer's Disease Patients. Front Aging Neurosci. 2020 Jul 28;12:220. doi: 10.3389/fnagi.2020.00220. PMID: 32848702; PMCID: PMC7399638. [CrossRef] [Google Scholar]
  • Shi J., Li Y., Zhang Y., Chen J., Gao J., Zhang T., Shang X., Zhang X. Baicalein Ameliorates Aß-Induced Memory Deficits and Neuronal Atrophy via Inhibition of PDE2 and PDE4. Front Pharmacol. 2021 Dec 13;12:794458. doi: 10.3389/fphar.2021.794458. PMID: 34966284; PMCID: PMC8711762. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.